Medline Inc. is 6.8x more valuable than GLAUKOS Corp by market capitalization ($49.12 B vs $7.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GKOS | MDLN |
|---|---|---|
| Market cap | $7.19 B | $49.12 B |
| US-listed rank | #1133 | #322 |
| Revenue (latest FY) | $507.44M | $28.43B |
| Net income (latest FY) | -$187.69M | $1.16T |
| Net margin | -37.0% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 1,014 | 103 |
Medline Inc. is 6.8x more valuable than GLAUKOS Corp by market capitalization ($49.12 B vs $7.19 B).
In their latest fiscal years, GLAUKOS Corp reported $507.44M in revenue while Medline Inc. reported $28.43B.
Full pages: GLAUKOS Corp and Medline Inc., or browse the full rankings.